Context as Contraindication: Ethical Challenges of Psychedelics and Other Neuroplasticity-Enhancing Drugs

Neuroethics · Published 2026-07-22 · DOI 10.1007/s12152-026-09663-3

Authors (4)

Nicolas Langlitz, Kyle Greenway, Chloé Pronovost-Morgan, Rebecca Gainsley

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Langlitz, N., Greenway, K., Pronovost-Morgan, C., et al. (2026). Context as Contraindication: Ethical Challenges of Psychedelics and Other Neuroplasticity-Enhancing Drugs. Neuroethics. https://doi.org/10.1007/s12152-026-09663-3

Related articles

• A Moratorium on Implantable Non-Medical Neurotech Until Effects on the Mind are Properly Understood · Neuroethics · 2025 · Same journal
• The Ghosts of Psychedelic Science: Haunting and Moral Repair · Neuroethics · 2025 · Same journal
• Ethical Considerations Toward Harmonizing Human and Machine Agency in Embodied Neurotechnologies · Neuroethics · 2026 · Same journal
• Precautionary Principle and Post-Mortem Brain Resuscitation · Neuroethics · 2025 · Same journal
• Regulating Next-Generation Implantable Brain-Computer Interfaces: Recommendations for Ethical Development and Implementation · Neuroethics · 2026 · Same journal
• The Psychological Risks of BCI-LLM Cognitive “Enhancement” · Neuroethics · 2025 · Same journal
• The Enduring Promise of Personalising Patient Preference Prediction · Neuroethics · 2026 · Same journal
• Damage and Restoration of Personal Identity in Deep Brain Stimulation: A Relational Perspective · Neuroethics · 2025 · Same journal
• Conflicting Interests and New Frontiers: A Role for Virtue Ethics in Cutting Edge Brain Research with Humans · Neuroethics · 2025 · Same journal
• When Are Psychiatric Patients Considered Less Credible? Implications for the Epistemic Injustice Debate · Neuroethics · 2026 · Same journal